08-29-2018 10:46 AM CET - Health & Medicine
Print

Macrolide Antibiotics Market Analysis with Survey Researcher's Study by Mustafa Nevzat İlaç, SM Biomed, Roche Holding AG, AstraZeneca, Sanofi, Novartis, Abbott Laboratories, Bayer, GlaxoSmithKline, Teva Pharmaceutical Industries, Merck & Co., Pfizer

Press release from: Data Bridge Market Research
Macrolide Antibiotics Market
Macrolide Antibiotics Market
Macrolide Antibiotics Market report is an in-depth study on Pharmaceutical industry. This report uses SWOT analysis to show the drivers and restrains of Macrolide Antibiotics Market. It includes the recent developments, products launches keeping the track for recent acquisitions, merges, joint ventures and competitive research in the Pharmaceutical industry. The report provides comprehensive study on market definition, classifications, applications, engagements, and global industry trends. It’s also main focus is market competition evaluation by listing the most significant key players and key brands driving the market the reports objective is also to forecast for year the years 2017 to 2024 in the Macrolide Antibiotics Market.

Market Definition: Global Macrolide Antibiotics Market

Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea. They inhibit protein synthesis in bacteria by binding to the 50S ribosomal element and effective against gram positive bacteria and intracellular pathogens such as Legionella, Mycoplasma and Chlamydia. It primarily act as a bacteriostatic agent against many strains of Corynebacteria, listeria, Moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia and Haemophilus sp.

Download exclusive PDF sample report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Market Analysis: Global Macrolide Antibiotics Market

The Global Macrolide Antibiotics Market accounted to grow at a CAGR of 12.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Major market drivers and restraints:

• Growth in skin infections.
• Rise in demand of drugs against bacterial skin infections.
• Macrolide antibiotics increase the risk of sudden cardiac death.

Market Segmentation: Global Macrolide Antibiotics Market

• The global macrolide antibiotics market is segmented by drugs into azithromycin, clarithromycin, erythromycin, fidaxomicinand telithromycin.

• On the basis of route of administration the market is segmented into oral and parenteral.

• On the basis of indication the market is segmented into infection due to Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis,symptomatic cat-scratch disease, Bacillaryangiomatosis, Peliosishepatis in patients with AIDS, cerebral toxoplasmosis, uncomplicated skin infections and others.

• On the basis of end user, the market is segmented into hospital, dermatology clinic, clinic, ambulatory center, research laboratories.

• On the basis of geography, global macrolide antibiotics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Order a Copy of Global Macrolide Antibiotics Market Report @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Competitive Analysis: Global Macrolide Antibiotics Market

The macrolide antibiotics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of macrolide antibiotics market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Macrolide Antibiotics Market

Merck Co. & Inc.,
Pfizer Inc.,
Sandoz International GmbH,
Teva Pharmaceutical Industries Ltd.,
GlaxoSmithKline plc.,
Johnson & Johnson Services, Inc.,
Bayer AG,
Abbott,
Novartis AG,
Sanofi,
AstraZeneca,
F. Hoffmann-La Roche AG,
Cempra, Inc.,
Macrolide Pharmaceuticals, Inc.,
SM Biomed,
Barkat Pharmaceutical Group,
Active Pharmaceutical Ingredient Manufacturing,
Mustafa NevzatİlaçSanayii A.Ş.,
Zhejiang Guobang Pharmaceutical Co., Ltd.,
Tianyin Pharmaceutical Co., Inc.,
Japan Pharmaceutical Manufacturers Association (JPMA)
Murli Krishna Pharma
Among others

Download Detailed TOC @ databridgemarketresearch.com/toc/?dbmr=global-macrolide-a...

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1208613 • Views: 593
More releasesMore releases

You can edit or delete your press release here: